Principal Scientist, External Innovation – Infectious Disease & Vaccines.
ElancoPrincipal Scientist, External Innovation – Infectious Disease & Vaccines.
ElancoLocation
Indianapolis, IN
Type
Full-time
Posted
11/4/2026
Compensation
Not listed
Job description
The Senior Advisor, External Innovation at Elanco is a critical expert focused on improving animal health by identifying and advocating for innovative solutions in infectious diseases and vaccines. This role involves close collaboration with R&D, global strategy teams, and senior leadership to evaluate cutting-edge technologies from various sectors. The position requires deep scientific expertise to influence the direction of innovation efforts for both pet and farm animals. The ideal candidate will play a key role in building a robust external innovation pipeline and making strategic recommendations.
Requirements
- An advanced degree in life sciences (PhD or DVM).
- A minimum of 7 years of experience in external innovation, technology scouting, or alliance management within the animal health, pharmaceutical, or biotechnology industry.
- Deep scientific expertise in infectious diseases, vaccines, or related immunology/virology fields.
Responsibilities
- Identify and evaluate external assets and technologies focused on infectious diseases and novel vaccine platforms.
- Lead the landscaping of opportunities and coordinate technical assessments with internal teams.
- Establish and manage key relationships with biotechnology companies, academic institutions, and pharmaceutical partners.
- Create compelling proposals for funding and governance, including scientific de-risking strategies.
- Make strategic go/no-go recommendations to governance and provide updates on external innovation efforts.
Benefits
- Employees at Elanco are often offered competitive compensation with annual bonus and equity eligibility, retirement plans (including a U.S. 401(k)), and comprehensive health coverage—medical, dental, vision, company-paid life and disability—and even pet insurance. Time-off and flexibility typically include generous PTO, U.S. mid-year and year-end paid shutdown weeks, parental leave, and flexible/remote work options. Employees also benefit from strong development programs (onboarding, course libraries, mentorship, nine ERGs, and tiered leadership programs) that support both professional growth and community involvement.
H-1B filing history
Public USCIS petition and DOL LCA counts · latest USCIS FY2026, LCA FY2026
Combined across 2 filing entities: Elanco Us Inc, Elanco Animal Health Inc
As of Aug 23, 2026
Initial approvals
4
FY2026
Approval rate
100.0%
FY2026
LCA certified
12
FY2026
Entry-level share
0.0%
FY2026
Initial approvals YoY
+3%
Trend
LCA certified YoY
-25%
Trend
Initial approvals by fiscal year
Approval rate by fiscal year
Continuing vs initial approvals
LCA certified positions by quarter
LCA certified positions by fiscal year
Based on public USCIS and DOL filings; not a sponsorship guarantee.
Is this posting expired or inaccurate?
